Literature DB >> 2418014

Purification and characterization of two isofunctional forms of NAD(P)H: quinone reductase from mouse liver.

H J Prochaska, P Talalay.   

Abstract

NAD(P)H:(quinone-acceptor) oxidoreductase (EC 1.6.99.2) is a widely distributed enzyme which promotes two-electron reductions of quinones and thereby protects cells against damage by reactive oxygen species generated during oxidative cycling of quinones and semiquinone radicals. Quinone reductase activity represents a minor component (about 0.006%) of mouse liver cytosolic proteins under basal (uninduced) conditions. Two isofunctional forms of this quinone reductase have been purified to homogeneity (1700-fold) in 30% yield from the liver cytosols of female CD-1 mice in which the enzymes were induced by administration of 2(3)-tert-butyl-4-hydroxyanisole. The purification involved ion exchange, hydrophobic, and affinity chromatographies. The two enzyme forms have been designated "hydrophilic" and "hydrophobic" based on the order of elution from phenyl-Sepharose. The more abundant hydrophilic form has been crystallized in the presence of FAD in the form of macroscopic tetragonal crystals. The two forms have similar isoelectric points (pI 9.2) and subunit molecular weights (Mr = 30,000) and probably exist as dimers in the native state. Purified preparations of the enzymes are equiactive with NADH and NADPH and show almost complete dependence on added FAD for catalytic activity. The Km values for FAD of the hydrophilic and hydrophobic forms are 2.72 and 1.72 nM, respectively. Their catalytic activities are the same and are remarkably high for nicotinamide nucleotide-linked dehydrogenases; maximum velocities (expressed per mg of pure enzyme) approach 4000 units/mg of protein under appropriate assay conditions. When menadione is the electron acceptor, the Km value for this quinone is very low (Km congruent to 2 microM). Both enzyme forms are potently inhibited by dicoumarol. Rabbit antisera against the hydrophilic quinone reductase precipitate quantitatively the entire quinone reductase activity of mouse liver cytosols obtained from animals maintained on a standard diet or those induced with 3-tert-butyl-4-hydroxyanisole. The quinone reductase activity of rat liver cytosols is also quantitatively precipitated by this antiserum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418014

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice.

Authors:  Heather E Kleiner; Xiaojun Xia; Junichiro Sonoda; Jun Zhang; Elizabeth Pontius; Jane Abey; Ronald M Evans; David D Moore; John DiGiovanni
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-15       Impact factor: 4.219

2.  Leflunomide induces NAD(P)H quinone dehydrogenase 1 enzyme via the aryl hydrocarbon receptor in neonatal mice.

Authors:  Amrit Kumar Shrestha; Ananddeep Patel; Renuka T Menon; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Biochem Biophys Res Commun       Date:  2017-02-10       Impact factor: 3.575

3.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

4.  Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

Authors:  Q Zhao; X L Yang; W D Holtzclaw; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts.

Authors:  Heather E Kleiner-Hancock; Runhua Shi; Angela Remeika; Delira Robbins; Misty Prince; Jennifer N Gill; Zanobia Syed; Patrick Adegboyega; J Michael Mathis; John L Clifford
Journal:  BMC Cancer       Date:  2010-07-26       Impact factor: 4.430

Review 6.  NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.

Authors:  M Belinsky; A K Jaiswal
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

7.  Effects of 5-azacytidine and methyl-group deficiency on NAD(P)H: quinone oxidoreductase and glutathione S-transferase in liver.

Authors:  G Wagner; U Pott; M Bruckschen; H Sies
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

8.  Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice.

Authors:  Misty Prince; Yan Li; Asper Childers; Ken Itoh; Masayuki Yamamoto; Heather E Kleiner
Journal:  Toxicol Lett       Date:  2008-12-30       Impact factor: 4.372

9.  Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.

Authors:  S Chen; P E Clarke; P A Martino; P S Deng; C H Yeh; T D Lee; H J Prochaska; P Talalay
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

10.  Biotransformation and tissue distribution of protopine and allocryptopine and effects of Plume Poppy Total Alkaloid on liver drug-metabolizing enzymes.

Authors:  Ya-Jun Huang; Pi Cheng; Zhuo-Yi Zhang; Shi-Jie Tian; Zhi-Liang Sun; Jian-Guo Zeng; Zhao-Ying Liu
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.